{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:40:07Z","timestamp":1773290407713,"version":"3.50.1"},"reference-count":47,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6706","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T22:09:14Z","timestamp":1473890954000},"page":"2571-2580","source":"Crossref","is-referenced-by-count":8,"title":["Gene Expression Profile of Inflammatory Myopathy with Malignancy is Similar to that of Dermatomyositis rather than Polymyositis"],"prefix":"10.2169","volume":"55","author":[{"given":"Tomoko","family":"Noda","sequence":"first","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiya","family":"Noda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Maeshima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292: 344-347, 1975.","DOI":"10.1056\/NEJM197502132920706"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403-407, 1975.","DOI":"10.1056\/NEJM197502202920807"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 1184: 134-153, 2011.","DOI":"10.1111\/j.1749-6632.2009.05119.x"},{"key":"4","unstructured":"4. Mosca M, Neri R, Pasero G, Bombardieri S. Treatment of the idiopathic inflammatory myopathies: a retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. Clin Exp Rheumatol 18: 451-456, 2000."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362: 971-982, 2003.","DOI":"10.1016\/S0140-6736(03)14368-1"},{"key":"6","unstructured":"6. Linklater H, Pipitone N, Rose MR, et al. Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 31: 767-769, 2013."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Dalakas MC, Sivakumar K. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol 9: 235-239, 1996.","DOI":"10.1097\/00019052-199606000-00015"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Mescam-Mancini L, Allenbach Y, Hervuer B, et al. Anti-Jo-1 antibody-positive patients show a characterustic necrotizing perifascicular myositis. Brain 138: 2485-2492, 2015.","DOI":"10.1093\/brain\/awv192"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sigurgeirsson B, Lindelof B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Eng J Med 326: 363-367, 1992.","DOI":"10.1056\/NEJM199202063260602"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wakata N, Kurihara T, Saito E, Kinoshita M. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41: 729-734, 2002.","DOI":"10.1046\/j.1365-4362.2002.01648.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134: 1087-1095, 2001.","DOI":"10.7326\/0003-4819-134-12-200106190-00008"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Hill CL, Zang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polumyositis: a population-based study. Lancet 357: 96-100, 2001.","DOI":"10.1016\/S0140-6736(00)03540-6"},{"key":"13","unstructured":"13. Chen D, Yuan S, Wu X, et al. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China. Clin Exp Rheumatol 32: 615-662, 2014."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lu X, Yang H, Shu X, et al. Factors predicting malignancy in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PloS One 9: e94128, 2014.","DOI":"10.1371\/journal.pone.0094128"},{"key":"15","unstructured":"15. Zantos D, Zhang Y, Felson D. The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21: 1855-1859, 1994."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yang Z, Lin F, Qin B, Liang Y, Zhong R. Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 42: 282-291, 2015.","DOI":"10.3899\/jrheum.140566"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ponyi A, Constantin T, Garami M, et al. Cancer-assosciated myositis: clinical features and prognostic signs. Ann N Y Acad Sci 1051: 64-71, 2005.","DOI":"10.1196\/annals.1361.047"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zahr ZA, Beer AN. Malignancy in myositis. Curr Rheumatol Rep 13: 208-215, 2011.","DOI":"10.1007\/s11926-011-0169-7"},{"key":"19","unstructured":"19. Shimizu J. Malignancy associated myositis. Brain and Nerve 62: 427-432, 2010 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 9: 449-453, 2010.","DOI":"10.1016\/j.autrev.2009.12.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Dank\u00f3 K, Ponyi A, Molnar AP, Andr\u00e1s C, Constantin T. Paraneoplastic myopathy. Curr Opin Rheumatol 21: 594-598, 2009.","DOI":"10.1097\/BOR.0b013e3283317fa5"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Levine SM. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 18: 620-624, 2006.","DOI":"10.1097\/01.bor.0000245721.02512.77"},{"key":"23","unstructured":"23. Linklater H, Pipitone N, Rose MR, et al. Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria. Clin Exp Rheumatol 31: 767-769, 2013."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Raju R, Dalakas MC. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128: 1887-1896, 2005.","DOI":"10.1093\/brain\/awh518"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Walsh RJ, Kong SW, Yao Y, et al. Type 1 interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 56: 3784-3792, 2007.","DOI":"10.1002\/art.22928"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Salajegheh M, Kong SW, Pinkus JL, et al. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 67: 53-63, 2010.","DOI":"10.1002\/ana.21805"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Greenberg SA, Sanoudou D, Haslett JN, et al. Molecular profiles of inflammatory myopathies. Neurology 59: 1170-1182, 2002.","DOI":"10.1212\/WNL.59.8.1170"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-\u03b1\/\u03b2-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664-678, 2005.","DOI":"10.1002\/ana.20464"},{"key":"29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2249.1994.tb06032.x","volume":"95","author":"E Bartoccioni","year":"1994","unstructured":"29. Bartoccioni E, Gallucci S, Scuderi F, et al. MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol 95: 166-172, 1994.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"30","first-page":"327","volume":"54","author":"D Rowe","year":"1983","unstructured":"30. Rowe D, Isenberg DA, Beverley PC. Monoclonal antibodies to human leukocytes antigens in polymyositis and muscular dystrophy. Clin Exp Immunol 54: 327-336, 1983.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. McDouall RM, Dunn MJ, Dubowitz V. Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci 89: 213-226, 1989.","DOI":"10.1016\/0022-510X(89)90023-3"},{"key":"32","unstructured":"32. Sallum AM, Kiss MH, Silva CA, et al. MHC class I and II expression in juvenile dermatomyositis skeletal muscle. Clin Exp Rheumatol 27: 519-526, 2009."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Das L, Blumbergs PC, Manavis J, Limaye VS. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Appl Immunohistochem Mol Morphol 21: 539-542, 2013.","DOI":"10.1097\/PAI.0b013e31827d7f16"},{"key":"34","unstructured":"34. Pedrol E, Grau JM, Casademont J, et al. Idiopathic inflammatory myopathies. Immunohistochemical analysis of the major histocompatibility complex antigen expression, inflammatory infiltrate phenotype and activation cell markers. Clin Neuropathol 14: 179-184, 1995."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Inukai A, Kuru S, Liang Y, et al. Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis. Muscle Nerve 23: 385-392, 2003.","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<385::AID-MUS10>3.0.CO;2-T"},{"key":"36","unstructured":"36. Sallum AM, Marie SK, Wakamatsu A, et al. Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis. J Rheumatol 31: 801-807, 2004."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Sallum AM, Kiss MH, Silva CA, et al. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis. Autoimmun Rev 5: 93-100, 2006.","DOI":"10.1016\/j.autrev.2005.05.008"},{"key":"38","unstructured":"38. Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Handa R. Increased expression of cell adhesion molecules in inflammatory myopathies: diagnostic utility and pathogenetic insights. Folia Neuropathol 47: 33-42, 2009."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Wakayama Y. Aquaporin expression in normal and pathological skeletal muscles: a brief review with focus on AQP4. J Biomed Biotechnol 2010: 731569, 2010.","DOI":"10.1155\/2010\/731569"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Wakayama Y, Jimi T, Inoue M, et al. Altered aquaporin 4 expression in muscles of Fukuyama-type congenital muscular dystrophy. Virchows Arch 443: 761-767, 2003.","DOI":"10.1007\/s00428-003-0887-y"},{"key":"41","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.4161\/cc.7.14.6272","volume":"7","author":"S Assereto","year":"2008","unstructured":"41. Assereto S, Mastrototaro M, Stringara S, et al. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies. Cell Cycle 7: 2199-2207, 2008.","journal-title":"Cell Cycle","ISSN":"https:\/\/id.crossref.org\/issn\/1538-4101","issn-type":"print"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Uchino M, Yamashita S, Uchino K, et al. Muscle biopsy findings predictive of malignancy in rare infiltrative dermatomyositis. Clin Neurol Neurosurg 115: 603-606, 2013.","DOI":"10.1016\/j.clineuro.2012.07.019"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polmyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85: 41-45, 2001.","DOI":"10.1054\/bjoc.2001.1699"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kuo CF, See LC, Yu KH, et al. Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 165: 1273-1279, 2011.","DOI":"10.1111\/j.1365-2133.2011.10595.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Chen YJ, Wu CY, Huang YL, Wang CB, Shen JL, Chang YT. Cancer risks of dermatomyositis and polymyositis; a nationwide cohort study in Taiwan. Arthritis Res Ther 12: R70, 2010.","DOI":"10.1186\/ar2987"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Liu WC, Ho M, Koh WP, et al. An 11-year review of dermatomyositis in Asian patients. Ann Acad Med Singapore 39: 843-847, 2010.","DOI":"10.47102\/annals-acadmedsg.V39N11p843"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Aggarwal R, Oddis CV. Paraneoplastic myalgias and myositis. Rheum Dis Clin North Am 37: 607-621, 2011.","DOI":"10.1016\/j.rdc.2011.09.007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/18\/55_55.6706\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:40:07Z","timestamp":1692502807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/18\/55_55.6706\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":47,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6706","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}